COMBINATION THERAPY WITH NINTEDANIB AND PREDNISOLONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

被引：0

作者：

Kato, Motoyasu ^{[1
]}

Nakamura, Takahiro ^{[1
]}

Kurokawa, Kana ^{[1
]}

Yamada, Tomoko ^{[1
]}

Ihara, Hiroaki ^{[1
]}

Takahashi, Fumiyuki ^{[1
]}

Sasaki, Shinichi ^{[2
]}

Takahashi, Kazuhisa ^{[1
]}

机构：

[1] Juntendo Univ, Grad Sch Med, Tokyo, Japan

[2] Juntendo Univ, Urayasu Hosp, Tokyo, Japan

来源：

RESPIROLOGY | 2018年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

AO212

引用

页码：86 / 86

页数：1

共 50 条

[41] Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A multicenter retrospective observational study in Japan [J].

Hisata, Shu ;

Bando, Masashi ;

Homma, Sakae ;

Kataoka, Kensuke ;

Ogura, Takashi ;

Izumi, Shinyu ;

Sakamoto, Susumu ;

Watanabe, Kizuku ;

Saito, Yoshinobu ;

Shimizu, Yasuo ;

Kato, Motoyasu ;

Nishioka, Yasuhiko ;

Hara, Hiromichi ;

Waseda, Yuko ;

Tanino, Yoshinori ;

Yatera, Kazuhiro ;

Hashimoto, Seishu ;

Mukae, Hiroshi ;

Inase, Naohiko .

RESPIRATORY INVESTIGATION, 2021, 59 (06) :819-826

[42] Nintedanib for idiopathic pulmonary fibrosis: An Asian perspective [J].

Chambers, Daniel C. .

RESPIROLOGY, 2016, 21 (08) :1342-1343

[43] Treatment of idiopathic pulmonary fibrosis with Nintedanib: an update [J].

Wongkarnjana, Amornpun ;

Yanagihara, Toyoshi ;

Kolb, Martin R. J. .

EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (12) :1139-1146

[44] Nintedanib for idiopathic pulmonary fibrosis in the Japanese population [J].

Jo, Helen E. ;

Corte, Tamera J. .

RESPIROLOGY, 2017, 22 (04) :630-631

[45] Nintedanib slows progression in idiopathic pulmonary fibrosis [J].

Weiss, Johannes .

PNEUMOLOGIE, 2018, 72 (02) :101-101

[46] Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Multiple Comorbidities [J].

Glaspole, I. ;

Bonella, F. ;

Bargagli, E. ;

Glassberg, M. K. ;

Caro, F. ;

Stansen, W. ;

Quaresma, M. ;

Orsatti, L. ;

Bendstrup, E. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201

[47] SHORT-TERM SAFETY OF NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS [J].

Saji, J. ;

Okamoto, M. ;

Matsuzawa, S. ;

Oyama, B. ;

Onoe, R. ;

Kakinuma, K. ;

Azagami, S. ;

Muraoka, H. ;

Morikawa, K. ;

Takemura, M. ;

Inoue, T. ;

Kida, H. ;

Furuya, N. ;

Handa, H. ;

Nishine, H. ;

Ishida, A. ;

Inoue, T. ;

Miyazawa, T. ;

Mineshita, M. .

RESPIROLOGY, 2016, 21 :36-36

[48] Disease Progression Events in Trials of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis [J].

Nathan, S. D. ;

Costabel, U. ;

Lancaster, L. H. ;

Corte, T. J. ;

Nunes, H. ;

Schinzel, B. ;

Quaresma, M. ;

Wells, A. U. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201

[49] Risk Factors For Hepatotoxicity Of Nintedanib In Japanese Patients With Idiopathic Pulmonary Fibrosis [J].

Ikeda, S. ;

Sekine, A. ;

Baba, T. ;

Yamakawa, H. ;

Oda, T. ;

Okuda, R. ;

Kitamura, H. ;

Ogura, T. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195

[50] Nintedanib and Pirfenidone Treatment Outcome Comparisons in Idiopathic Pulmonary Fibrosis Patients [J].

Lee, Y. ;

Borges, E. ;

Spitznogle, A. ;

Sullivan, C. ;

Booth, S. ;

Ruia, R. ;

Chang, K. ;

Fadell, F. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2025, 211

← 1 2 3 4 5 →